The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003
Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007
Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Corticosteroid insensitivity in severe asthma: Impaired nuclear translocation of glucocorticoid receptor in airway smooth muscle cells Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012
Influence of inhaled corticosteroids on airway epithelial cell mediator release in wheezing children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
Inhaled corticosteroids and β2 -agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018
The PAR2 -activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004
The mechanisms of glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma (ABA) Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002